Universal-Beteiligungs- und Servicegesellschaft
RCKT icon

Universal-Beteiligungs- und Servicegesellschaft’s Rocket Pharmaceuticals RCKT Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,406
Closed -$143K – 2093
2025
Q1 		$143K Buy
+21,406
New +$211K ﹤0.01% 1925

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's RCKT Position: Q2 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Rocket Pharmaceuticals (RCKT) in Q2 2025, closing a stake of 21,406 shares — an estimated $143K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RCKT in Q1 2025 and held it in 1 quarter. The position peaked at $143K in Q1 2025. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Rocket Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 21,406 Rocket Pharmaceuticals shares in Q2 2025, an estimated $143K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Rocket Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Universal-Beteiligungs- und Servicegesellschaft's Rocket Pharmaceuticals position peaked at $143K in Q1 2025.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2025, filed 11 Aug 2025.